bmiMD

MyDietDoc

MyDietDoc sells physician-supervised weight-loss programs delivered 100 % online. Core offerings include compounded GLP-1 medications (semaglutide and tirzepatide), metabolic testing kits, and monthly telehealth coaching subscriptions; prices sit in the mid-to-premium tier, typically $250-$450 per month before insurance. The brand differentiates by pairing every patient with a U.S.-licensed clinician who prescribes and titrates medication without requiring in-person visits, then ships medication from an affiliated compounding pharmacy within 3-5 days. All plans include unlimited messaging, nutrition tracking, and dose adjustments, positioning MyDietDoc as a turnkey medical pathway rather than a supplement or diet plan. Primary buyers are busy professionals aged 25-55 with 30+ lbs to lose who want clinically proven results but lack time for brick-and-mortar clinics; they value privacy, speed, and medical oversight over flashy lifestyle branding. Messaging emphasizes science, safety, and sustainable weekly fat loss rather than cosmetic quick fixes. MyDietDoc competes with telehealth GLP-1 startups, cash-pay medical weight-loss chains, and direct-to-consumer supplement brands. It separates itself by bundling prescription authority, personalized titration, and ongoing physician access into one flat monthly fee, avoiding the upsell tiers common among competitors while remaining fully virtual.

Your doctor adjusts your medication while you live your life

• Sustainable

Joinweightcare

Joinweightcare is a direct-to-consumer, online-only wellness platform that bundles prescription GLP-1 weight-loss medications (compounded semaglutide and tirzepatide) with telehealth consults, at-home lab kits, and digital coaching. Medication plans start around $199 for the first month and move to $299–$399 per month thereafter, placing the brand in the mid-range tier below big-pharma list prices but above discount peptide sites. All orders are fulfilled by partner compounding pharmacies and shipped to 40+ U.S. states after an asynchronous doctor approval. The company’s core promise is “prescription + support in one click”: patients complete a 5-minute intake, receive same-day provider review, and get ongoing dose adjustments without leaving the app. Every subscription includes unlimited messaging with the prescribing clinician, a smart-scale integration, and a calorie-tracking app at no extra cost. This bundled model has produced a 4.8/5 Trustpilot rating and a cohort where 78 % of members report ≥10 % body-weight reduction within six months. Typical buyers are 30-55-year-old professionals—predominantly women—who have BMI ≥27 and have cycled through commercial diets without lasting results. They value medical legitimacy, privacy (no in-person visits), and predictable cash pricing that avoids insurance denials. The brand speaks in clinical but encouraging tones, emphasizing metabolic health over vanity metrics. Joinweightcare competes with telehealth pill-and-shot startups, cash-pay med-spas, and traditional weight-loss programs. It differentiates by combining compounded GLP-1 access with continuous clinician oversight and behavioral tools under one flat monthly fee, eliminating the need for separate pharmacy, coaching, and lab invoices.

Your doctor, your medication, your coach, all month long

Ivim Health

Ivim Health is a telemedicine platform that prescribes and ships GLP-1 receptor agonist weight-loss medications (semaglutide and tirzepatide) and complementary metabolic-support supplements. All care is delivered online through a $129–$149 monthly membership that includes provider consults, unlimited messaging, and free 2-day pharmacy shipping; the drugs themselves are billed separately and priced at or below typical retail pharmacy levels. The company operates only through its website—no physical clinics—and accepts HSA/FSA cards but not insurance for the membership fee. The brand’s core promise is “MD-led weight loss in 24 hr”: patients complete an intake, receive same-day provider review, and—if medically eligible—have medication dispatched from Ivim’s partnered sterile compounding pharmacies. Ivim formulates its own flavored sublingual and injection kits, advertises transparent batch testing, and provides a mobile dashboard that syncs with smart scales to track BMI, visceral fat, and glucose trends. Its most visible offering is the “QuickStart GLP-1 Trio,” a four-week introductory pack that bundles titrated semaglutide, B12 shots, and craving-control lozenges. Typical customers are U.S. adults 25-55 with BMI ≥27 who want clinical-grade obesity treatment without long waitlists or insurance hurdles; many are busy professionals, post-partum women, and remote workers already comfortable with subscription services. They value speed, privacy, and data-driven feedback, and they prefer a cash-pay model that keeps treatment off employer health records. Ivim competes with national telehealth weight-loss programs, cash-pay clinic chains, and compound pharmacies that market directly on social media. It differentiates by integrating prescription issuance, in-house drug manufacturing, and biometric tracking inside one vertically controlled platform, promising faster fulfillment (24 hr vs. 3-7 days) and tighter clinical oversight (MDs, not nurse pools) than most low-cost rivals while staying cheaper than concierge metabolic clinics.

Weight loss that actually keeps up with your life

Orderlymeds

Orderlymeds is an online-only telehealth pharmacy that focuses on GLP-1 receptor agonist weight-loss injections—primarily compounded semaglutide and tirzepatide—sold in 4-, 8-, and 12-week subscription kits. Prices sit in the mid-range bracket: about $299-$549 per month, including medication, tele-consult, supplies, and free 2-day shipping; no insurance is required. The site also stocks supporting items such as alcohol swabs, sharps containers, and vitamin B12 lipo-combo add-ons, all bundled into the same checkout flow. The brand’s core promise is “doctor-guided, pharmacy-delivered” in one seamless loop: patients complete an intake form, are reviewed by a U.S.-licensed clinician within 24 h, and receive medication from an affiliated PCAB-certified compounding pharmacy. All vials are compounded on-demand in the United States, labeled with batch and beyond-use dates, and shipped cold-chain in reusable gel-pack mailers. Orderlymeds markets transparency—posting third-party lab results for potency and sterility on each product page—and offers a 30-day refund if treatment is discontinued for medical reasons. Typical buyers are 25-55-year-old professionals who want clinically proven weight-loss medication without brick-and-mortar clinic visits or insurance hurdles; many report BMI just above insurance-cutoff thresholds or prefer privacy. The brand speaks to value-driven pragmatists who track macros, use wearables, and favor subscription convenience over luxury aesthetics. Orderlymeds competes with national telehealth platforms, cash-pay pharmacy networks, and med-spa chains that also prescribe GLP-1 drugs. It differentiates by keeping the entire stack—consult, compounding, and fulfillment—under one digital roof, avoiding third-party pharmacy delays and offering flat, published pricing with no membership or hidden consult fees.

Doctor-approved weight loss, compounded fresh, shipped to your door in days

Shedrx

Shedrx is a direct-to-consumer telehealth brand that prescribes and ships GLP-1 receptor-agonist weight-loss medications (semaglutide and tirzepatide) and complementary metabolic-support supplements. All care is handled online through a virtual consultation, prescription, and monthly subscription that lands between mid-range and premium pricing—typically $299-$399 for a 4-week compounded injectable supply. The company operates exclusively online; no physical pharmacies or clinics are involved. The brand’s core edge is speed-to-treatment: most patients complete intake, provider review, and pharmacy dispatch within 48 hours, with medication arriving cold-shipped to their door. Shedrx formulates its own compounded versions of the active ingredients, allowing it to stay in stock during national shortages and to offer dose-titration packs that larger drug-makers do not. A mobile dashboard tracks dosage, side-effects, and progress, reinforcing adherence and data-driven adjustments. The typical buyer is a 30-55-year-old U.S. resident with a BMI ≥27 who wants physician-guided weight loss without insurance hurdles or in-person visits. Convenience, discretion, and a “life-hack” mindset drive the purchase; customers value being able to start therapy quickly while still under clinician oversight rather than relying on lifestyle apps alone. Shedrx competes in the fast-growing tele-weight-loss segment populated by digital clinics and wellness subscription services. It differentiates through guaranteed compounded-drug availability, transparent flat pricing, and integrated progress tracking, positioning itself as a faster, more reliable alternative to both traditional insurance-based programs and generic online pharmacies.

Weight loss that actually ships faster than your excuses

Trimrx

Trimrx is an online-only direct-to-consumer brand that sells compounded GLP-1 weight-loss injections—primarily semaglutide and tirzepatide—along with telehealth consultations, starter supply kits, and monthly refill plans. All medications are prescribed and fulfilled through the company’s U.S.-partnered pharmacies; no insurance is required. Pricing sits in the mid-range tier: starter programs open at roughly $299 and monthly refills run $399–$499, placing the brand below most in-clinic peptide clinics but above budget pill-based alternatives. The company’s core promise is “prescription GLP-1 in 48 hours”: patients complete an asynchronous intake, a state-licensed clinician reviews within one business day, and medication ships overnight from an affiliated pharmacy. Doses are customized to the nearest 0.1 mg, vials arrive in temperature-controlled packaging with pre-loaded syringes, and unlimited dosage adjustments are included. Trimrx markets itself as the fastest, most transparent tele-GLP-1 option, publishing real-time pharmacy inventory and batch-level Certificates of Analysis online. Trimrx targets busy professionals aged 25-55 who want clinically proven weight-loss injectables without clinic visits, insurance hurdles, or brand-name mark-ups. Customers value speed, privacy, and data—many track body-composition metrics and share progress in the brand’s private Slack community. The aesthetic is clean, medical-minimalist, appealing to consumers who already subscribe to DTC services for hair, skin, or hormone care. Competitors include other telehealth platforms offering compounded semaglutide, cash-pay medical spas, and traditional pharmacies. Trimrx differentiates through faster fulfillment (48-hour average), flat monthly pricing that covers all clinician touchpoints, and public lot-level testing—practices not universally offered by rival tele-GPL-1 sites.

GLP-1 in 48 hours, transparent dosing, no clinic visits required

Portal Shedrx

Portal Shedrx is an online-only telehealth brand that prescribes and ships GLP-1 receptor agonist weight-loss medications—primarily compounded semaglutide and tirzepatide—directly to patients. After a $49 virtual consultation, qualifying customers receive monthly subcutaneous injection kits priced at $199–$399, placing the offer in the mid-range between discount compounding pharmacies and premium brick-and-mortar clinics. All prescriptions are filled through partnered U.S. compounding pharmacies and delivered in temperature-controlled packaging. The company’s core edge is a fully digital, subscription-based model that bundles provider consults, dosage titration support, and medication into one recurring shipment. Each patient is assigned a clinician who monitors progress via a HIPAA-compliant portal, and refills are automatically calibrated to the individual’s titration schedule. This integrated “prescription-to-doorstep” system lets users avoid retail pharmacies and in-office visits while still accessing the same active ingredients found in higher-priced name-brand injectables. Typical buyers are 25-55-year-old U.S. residents with a BMI ≥27 who want clinically significant weight loss without insurance hurdles or time-consuming clinic appointments. The brand speaks to value-driven, tech-savvy consumers who prioritize convenience, privacy, and transparent cash pricing over traditional healthcare rituals. Portal Shedrx competes with telehealth platforms, med-spa chains, and cash-pay compounding pharmacies that market similar GLP-1 programs. It differentiates by combining proprietary clinician oversight, fixed monthly pricing that includes medication, and an interface that automates dose adjustments—delivering a more cohesive, app-managed experience than piecemeal prescription or injection services.

Weight loss that actually fits your life, delivered to your door